Barclays PLC Astrazeneca PLC Put Options Transaction History

Barclays PLC

$854 Billion
Q3 2025

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $1.3 Million - $1.5 Million	20,000 New	20,000 $1.4 Million
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $2.81 Million - $3.35 Million	-43,000 Reduced 53.75%	37,000 $2.72 Million
Q4 2024 Feb 13, 2025	SELL	$63.2 - $79.58 $25.3 Million - $31.9 Million	-400,900 Reduced 83.36%	80,000 $5.24 Million
Q3 2024 Nov 15, 2024	BUY	$76.67 - $87.62 $36.9 Million - $42.1 Million	480,900 New	480,900 $37.5 Million
Q4 2023 Feb 15, 2024	BUY	$61.89 - $69.28 $5.63 Million - $6.3 Million	90,900 New	90,900 $6.12 Million

Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $3.79 Million - $4.3 Million	60,000 Added 73.62%	141,500 $9.82 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $4.42 Million - $5.74 Million	81,500 New	81,500 $5.53 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $10,804 - $12,766	-200 Reduced 11.76%	1,500 $87,000
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $2.6 Million - $3.34 Million	-60,400 Reduced 97.26%	1,700 $90,000
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $3.33 Million - $4.52 Million	-88,100 Reduced 58.66%	62,100 $2.77 Million
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $309,958 - $368,358	7,300 Added 5.11%	150,200 $7.49 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $20.4 Million - $23.1 Million	-508,400 Reduced 78.06%	142,900 $6.37 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $22.3 Million - $25 Million	599,300 Added 1152.5%	651,300 $26.9 Million
Q1 2019 May 15, 2019	BUY	$35.49 - $43.02 $159,705 - $193,590	4,500 Added 9.47%	52,000 $2.1 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $239,590 - $269,685	6,500 Added 15.85%	47,500 $1.8 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $4.28 Million - $4.89 Million	-123,000 Reduced 75.0%	41,000 $1.62 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $431,874 - $463,124	12,500 Added 8.25%	164,000 $5.76 Million
Q1 2018 May 15, 2018	SELL	$32.97 - $36.63 $7.99 Million - $8.88 Million	-242,300 Reduced 61.53%	151,500 $5.3 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $234,257 - $253,894	7,300 Added 1.89%	393,800 $13.7 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $11.2 Million - $13.1 Million	386,500	386,500 $13.1 Million

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

49.1M
Shares

$4.39 Billion
0.4% of portfolio
Primecap Management CO Pasadena, CA

39.9M
Shares

$3.56 Billion
2.42% of portfolio
Bank Of America Corp Charlotte, NC

32.6M
Shares

$2.92 Billion
0.18% of portfolio
Wellington Management Group LLP Boston, MA

32.3M
Shares

$2.89 Billion
0.45% of portfolio
Capital International Investors Los Angeles, CA

25.1M
Shares

$2.24 Billion
0.33% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account